3GW-20621-76148

3 vaccinations 3 coded responses 35 check-ins 2 free-text entries 4 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 630 / MO
Registered: 2021-03-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1090960 (opens in a new window)	high	8 / 11	2	0 of 7 VAERS symptoms	same dose (1)	MO matches	2021-03-06 / 2021-03-07 / 2021-03-11 received the same day as the last call	case 306792

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-06
Registered in v-safe
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
2021-03-06
Health check-in — day 0, dose 1
Feeling: Fair · Headache

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-07
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-08
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-10
Call 1 — Left Voicemail
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-11
Call successful
Completed over the phone
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-13
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-20
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-27
Health check-in — day 21, single dose
Feeling: Good

Adult check-in
2021-04-03
Health check-in — day 28, single dose
Feeling: Good

Adult check-in
2021-04-10
Health check-in — day 35, single dose
Feeling: Good

Adult check-in
2021-04-17
Health check-in — day 42, single dose
Feeling: Good

Adult check-in
2021-06-05
Survey response — 3 months, dose 1
MedDRA: Office visit, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional

Free text: Symptoms: Gestational diabetes · Healthcare visit (other): In office visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-05
Report sent to call center — 3 months, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-08
Call 1 — Left Voicemail
2021-09-04
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-10-22
Dose 2 — Pfizer-BioNTech
2021-10-31
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-11-05
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-11-12
Health check-in — day 21, dose 2
Feeling: Fair

Adult check-in
2021-11-19
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-11-26
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-12-03
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-01-21
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-04-22
Survey response — 6 months, dose 2
MedDRA: Gastrooesophageal reflux disease, Office visit, Perinatal depression, Postpartum anxiety — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Postpartum depression, postpartum anxiety and GERD. · Healthcare visit (other): In person with primary doctor

MedDRA releases: 2024-11 · check-in free text available
2022-04-22
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-25
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-22
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2023-01-05
Dose 3 — Moderna
2023-01-06
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2023-01-07
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2023-01-08
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2023-01-10
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2023-01-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Fatigue or tiredness, Nausea

Adult check-in
2023-01-14
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2023-01-21
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2023-01-26
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2023-02-02
Survey response — day 28, dose 3
MedDRA: Cough, Nasal congestion — Feeling: Fair

MedDRA releases: 2024-11
2023-02-09
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2023-02-16
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2023-04-08
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-06	Janssen/Johnson & Johnson
2	2021-10-22	Pfizer-BioNTech	No
3	2023-01-05	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2021-03-07	Successful	Completed over the phone
2021-03-08	Successful 2021-03-11	Completed over the phone
2021-06-05	Unsuccessful	Reported to VAERS during previous contact from GDIT
2022-04-22	Successful 2022-04-25	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 8 — 3 months, dose 1

2021-06-05

Symptoms: Gestational diabetes

Healthcare visit (other): In office visit

Release 11 — 6 months, dose 2

2022-04-22

Symptoms: Postpartum depression, postpartum anxiety and GERD.

Healthcare visit (other): In person with primary doctor

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	Cough	·	·	✓
SD	Gastrooesophageal reflux disease	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Perinatal depression	·	·	✓
SD	Postpartum anxiety	·	·	✓
SD	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release